Search

The purpose of the present study is to evaluate the effect of curcumin as a natural compound against radiation induced γ-foci and stable chromosome aberrations. Whole blood samples form three human volunteers were pretreated with curcumin at different concentrations (0.5, 10, 20 and 100 μg/ml). After 1-hour incubation, the lymphocytes were exposed to γ-rays (0.05, 0.5, 1 and 2 Gy). Radiation induced changes in cells were quantified using γ-H2AX/53BP1 assay and FISH analysis. Our results have shown that curcumin significantly reduced the frequency of both γ-foci and translocations. We found concentration-dependent increase of curcumin protective effect on γ-H2AX/53BP1 foci formation at all radiation doses. Concerning the translocations, after 0.05 and 0.5 Gy γ-rays the values of genomic frequencies are comparable within each dose and we did not observe any impact of curcumin. The most protective effect after 1 Gy exposure was found at 100 μg/ml curcumin. At 2 Gy irradiation, the maximum protection was achieved at 0.5 and 10 μg/ml of curcumin. Concentrations of 20 and 100 μg/ml also prevent lymphocytes but to less extent. Our in vitro study indicates radioprotective efficacy of curcumin against γ-ray induced damages in human lymphocytes. This observation suggests that curcumin may play a role to protect patients undergoing radiological procedures. [ABSTRACT FROM AUTHOR]

Curcumin is a component of natural spice Curcuma longa. It is known that this polyphenol has been shown to exhibit anti-inflammatory, anticancer, antiviral, antioxidant and antibacterial activities. The mechanism of curcumin effectiveness on both healthy and cancer tissues is still unclear. Aims: In vitro assessment of curcumin effect on both double-strand breaks and chromosomal translocations frequency, after γ-irradiation. Methods: Human peripheral blood samples were pre-treated with different concentrations of curcumin (0.5 μg/ml; 10 μg/ml; 20 μg/ml and 100 μg/ml). Thereafter they were exposed to 60Co γ-rays using various irradiation doses (0.05 Gy; 0.5 Gy; 1 Gy and 2 Gy). Both γ-H2AX/53BP1 foci assay and FISH analysis were used to evaluate DNA double-strand breaks and translocation frequencies. Results: Curcumin pre-treatment exhibited significant lower γ-H2AX/53BP1 foci appearance and reduced translocations frequency in irradiated compared to untreated lymphocytes. At 1 Gy irradiation and 10 μg/ml curcumin, the reduction of total translocations frequency was 42%. We found that at 2 Gy irradiation, the most protective concentration was 0.5 μg/ml curcumin. In this case, translocations declined almost twofold compared to curcumin nontreated cells. Conclusion: The present in vitro study demonstrates that curcumin reduces both γ-H2AX/53BP1 foci and translocations occurrence in peripheral blood lymphocytes, after γ-irradiation. [ABSTRACT FROM AUTHOR]

Purpose: In the framework of RENEB, several biodosimetry exercises were conducted analyzing different endpoints. Among them, the analysis of translocations is considered the most useful method for retrospective biodosimetry due to the relative stability of their frequency with post irradiation time. The aim of this study was to harmonize the accuracy of translocation-based biodosimetry within the RENEB consortium. Materials and methods: An initial telescoring exercise analyzing FISH metaphase images was done to harmonize chromosome aberration descriptions. Then two blind intercomparison exercises (IE) were performed, by sending irradiated blood samples to each partner. Samples were cultured and stained by each partner using their standard protocol and translocation frequency was used to produce dose estimates. Results: The coefficient of variation in the 1st IE (CV = 0.34) was higher than in the 2nd IE (CV = 0.16 and 0.23 in the two samples analyzed), for the genomic frequency of total translocations. Z-score analysis revealed that eight out of 10 and 17 out of 20 dose estimates were satisfactory in the 1st and 2nd IE, respectively. Conclusions: The results obtained indicate that, despite the problems identified in few partners, which can be corrected, the RENEB consortium is able to carry out retrospective biodosimetry analyzing the frequency of translocations by FISH. [ABSTRACT FROM AUTHOR]